Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Decker

Showing results (251-260 of 282) with videos related to

Pageof 29
Sort By:
Pediatrics|September 1, 1995
The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoidsJ A Englund, E L Anderson, G F Reed, et al.
Antiviral Research|July 1, 1993
Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitorR W Buckheit, M G Hollingshead, J Germany-Decker, et al.
Leukemia Research|April 28, 2000
Myelodysplastic syndrome at a large tertiary care community hospital: analysis according to the international prognostic scoring systemI A Jaiyesimi, J A Friedline, J C Mattson, et al.
Pediatrics|September 1, 1995
Simultaneous administration of Haemophilus influenzae type b vaccine with acellular or whole-cell pertussis vaccine: effects on reactogenicity and immune responses to pertussis vaccinesM B Rennels, G F Reed, M D Decker, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1993
Diarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptaseJ B McMahon, R J Gulakowski, O S Weislow, et al.
Pediatrics|November 14, 1997
A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old childrenM E Pichichero, M A Deloria, M B Rennels, et al.
Plos One|August 16, 2024
Self-reported menses physiology is positively modulated by a well-formulated, energy-controlled ketogenic diet vs. low fat diet in women of reproductive age with overweight/obesityMadison L Kackley, Alex Buga, Milene L Brownlow, et al.
Antiviral Research|September 1, 1994
Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitorsR W Buckheit, V Fliakas-Boltz, W D Decker, et al.
Pediatrics|September 1, 1995
A randomized comparison of reactogenicity and immunogenicity of two whole-cell pertussis vaccinesM C Steinhoff, G F Reed, M D Decker, et al.
AIDS (London, England)|December 22, 2010
Multiple independent lineages of HIV-1 persist in breast milk and plasmaRebecca R Gray, Marco Salemi, Amanda Lowe, et al.
Pageof 29

Showing results (251-260 of 282) with videos related to

Sort By:
Pageof 29
Pediatrics|September 1, 1995
The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoidsJ A Englund, E L Anderson, G F Reed, et al.
Antiviral Research|July 1, 1993
Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitorR W Buckheit, M G Hollingshead, J Germany-Decker, et al.
Leukemia Research|April 28, 2000
Myelodysplastic syndrome at a large tertiary care community hospital: analysis according to the international prognostic scoring systemI A Jaiyesimi, J A Friedline, J C Mattson, et al.
Pediatrics|September 1, 1995
Simultaneous administration of Haemophilus influenzae type b vaccine with acellular or whole-cell pertussis vaccine: effects on reactogenicity and immune responses to pertussis vaccinesM B Rennels, G F Reed, M D Decker, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1993
Diarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptaseJ B McMahon, R J Gulakowski, O S Weislow, et al.
Pediatrics|November 14, 1997
A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old childrenM E Pichichero, M A Deloria, M B Rennels, et al.
Plos One|August 16, 2024
Self-reported menses physiology is positively modulated by a well-formulated, energy-controlled ketogenic diet vs. low fat diet in women of reproductive age with overweight/obesityMadison L Kackley, Alex Buga, Milene L Brownlow, et al.
Antiviral Research|September 1, 1994
Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitorsR W Buckheit, V Fliakas-Boltz, W D Decker, et al.
Pediatrics|September 1, 1995
A randomized comparison of reactogenicity and immunogenicity of two whole-cell pertussis vaccinesM C Steinhoff, G F Reed, M D Decker, et al.
AIDS (London, England)|December 22, 2010
Multiple independent lineages of HIV-1 persist in breast milk and plasmaRebecca R Gray, Marco Salemi, Amanda Lowe, et al.
Pageof 29